A History of the US Medical Cannabis Movement and Its Importance to Pediatricians

SCC member Kevin M. Takakuwa, MD outlines on the historical impact of cannabis and its relevance to pediatric practice. The article highlights how cannabis may benefit seizure disorders in children and young adults.

A Not-So-Proud Memory

During Pride Month, we owe it to history to recall an embarrassing, tragic twist in the relationship between AIDS activism and the medical marijuana movement.

How the Aids Epidemic Catalyzed the Medical Marijuana Movement

The historical account of Dennis Peron, the medical cannabis and human rights activist who was instrumental in bringing attention to AIDS and changing cannabis policy in California.

Can CBD Counter Binge-Eating?

Findings suggest that CBD may have therapeutic potential to reduce binge eating and the development of obesity, according to a paper published by Addiction Biology.

GW Opposed Blumenauer-McClintock Amendment

On June 19 the House of Representatives voted to add the Blumenauer-McClintock Amendment —which would prevent the Department of Justice from enforcing federal law in states that have legalized adult-use marijuana—to an appropriations bill.

Add MJ Journals: ‘Medical Cannabis and Cannabinoids’

“Medical Cannabis and Cannabinoids” is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing field of medical cannabis and cannabinoids.

JAMA op-ed: ‘Educating Physicians About MJ’

Marijuana use is prevalent both in states where it is legal to some degree and in states where it is not. However, evidence suggests that many physicians may be unprepared for this reality.

Can Medical Marijuana Help with Dementia?

There’s no official endorsement of medical cannabis for dementia, but with or without scientific data, more and more people are willing to investigate cannabis to treat their loved ones.

Humboldt Humbled by Legalization

Although it’s entitled “How Legalization Changed Humboldt County Marijuana,” Emily Witt’s article in the New Yorker is not about new plant varieties but about new social realities. 

You Must Remember This (Re: Mushrooms)

Eating mushrooms may reduce the risk of cognitive impairment, according to a study published in the Journal of Alzheimer’s Disease.

Epidiolex Weighs in at Schedule V

EPIDIOLEX®, a cannabidiol oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S. Drug Enforcement Administration. But CBD remains on Schedule I, due to its supposed abuse liability.

Russo’s Grand Unified Theory

Dr. Ethan Russo’s research on the Grand Unified Theory (GUT) that discusses how cannabis-based treatment and nutritional approaches can address five conditions that are difficult to treat with conventional medicine.